Preoperative risk stratification for pulmonary complications after neoadjuvant therapy and esophagectomy in locally advanced esophageal squamous cell carcinoma: a retrospective cohort study
Huan Lv, Ming Wang, Mingchuang Zhu, Tao Lu, Yong Ma, Ruirui Han · 2026
Read Preoperative risk stratification for pulmonary complications after neoadjuvant therapy and esophagectomy in locally advanced esophageal squamous cell carcinoma: a retrospective cohort study by Huan Lv, Ming Wang, Mingchuang Zhu, Tao Lu, Yong Ma, Ruirui Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13650297.txt.
Description
Huan Lv and five colleagues build a tool to estimate, before surgery, which patients with advanced esophageal cancer will develop lung complications afterward. These patients first receive drug treatment to shrink the tumor, then undergo removal of the esophagus, and lung problems are a leading source of suffering after that operation.
The team reviewed 232 patients treated during 2023 and 2024, of whom just under a third developed lung complications. Five facts known before surgery went into the model: smoking history raised the odds, while high blood pressure, immune-based drug treatment, inhaled medication, and breathing exercises each lowered them. The model sorted patients with acceptable accuracy and held up under internal checking. Presented as a scoring chart, it is meant to guide preparation for surgery, though the authors say outside testing must come before routine use.
Catalog record
| CREATOR | Huan Lv, Ming Wang, Mingchuang Zhu, Tao Lu, Yong Ma, Ruirui Han |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |